MyoGene Bio

Los Angeles, United States

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

$400K raised

Nov 2025

Venture - Series Unknown

Top Investors

MassChallengeParent Project Muscular DystrophyDuchenne UKCureDuchenne Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MyoGene Bio raised?

MyoGene Bio has raised $400K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.

Who are MyoGene Bio's investors?

MyoGene Bio's investors include MassChallenge, Parent Project Muscular Dystrophy, Duchenne UK, CureDuchenne Ventures.

Where is MyoGene Bio headquartered?

MyoGene Bio is headquartered in Los Angeles, United States.

What does MyoGene Bio do?

MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.

What stage is MyoGene Bio at?

MyoGene Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 4, 2025.

MLA

"MyoGene Bio — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/myogene-bio. Accessed June 4, 2026.

APA

VCBacked. (2025). MyoGene Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/myogene-bio

Wikipedia (cite web)

{{cite web |title=MyoGene Bio — Funding & Investors |url=https://www.vcbacked.co/company/myogene-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 4, 2025.